Browse > Article
http://dx.doi.org/10.5483/BMBRep.2016.49.7.246

c-Jun N-terminal Kinase (JNK) induces phosphorylation of amyloid precursor protein (APP) at Thr668, in okadaic acid-induced neurodegeneration  

Ahn, Ji-Hwan (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
So, Sang-Pil (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
Kim, Na-Young (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
Kim, Hyun-Ju (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
Yoon, Seung-Yong (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
Kim, Dong-Hou (Alzheimer's Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
BMB Reports / v.49, no.7, 2016 , pp. 376-381 More about this Journal
Abstract
Several lines of evidence have revealed that phosphorylation of amyloid precursor protein (APP) at Thr668 is involved in the pathogenesis of Alzheimer's disease (AD). Okadaic acid (OA), a protein phosphatase-2A inhibitor, has been used in AD research models to increase tau phosphorylation and induce neuronal death. We previously showed that OA increased levels of APP and induced accumulation of APP in axonal swellings. In this study, we found that in OA-treated neurons, phosphorylation of APP at Thr668 increased and accumulated in axonal swellings by c-jun N-terminal kinase (JNK), and not by Cdk5 or ERK/MAPK. These results suggest that JNK may be one of therapeutic targets for the treatment of AD.
Keywords
Alzheimer's disease; APP; JNK; Okadaic acid; PP2A;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Gomez-Isla T, Hollister R, West H et al (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24   DOI
2 Hardy J and Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356   DOI
3 Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM and Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917   DOI
4 Tanimukai H, Grundke-Iqbal I and Iqbal K (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 166, 1761-1771   DOI
5 Tachibana K, Scheuer PJ, Tsukitani Y et al (1981) Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J Am Chem Soc 103, 2469-2471   DOI
6 Arias C, Sharma N, Davies P and Shafit-Zagardo B (1993) Okadaic acid induces early changes in microtubuleassociated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem 61, 673-682   DOI
7 Sun L, Liu SY, Zhou XW et al (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118, 1175-1182   DOI
8 Kamat PK, Rai S and Nath C (2013) Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology. Neurotoxicology 37, 163-172   DOI
9 Wang Z, Yang L and Zheng H (2012) Role of APP and Abeta in synaptic physiology. Curr Alzheimer Res 9, 217-226   DOI
10 Lee MS, Kao SC, Lemere CA et al (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163, 83-95   DOI
11 Sano Y, Nakaya T, Pedrini S et al (2006) Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. PLoS ONE 1, e51   DOI
12 Iijima K, Ando K, Takeda S et al (2000) Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 75, 1085-1091   DOI
13 Liu F, Su Y, Li B et al (2003) Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett 547, 193-196   DOI
14 Rockenstein E, Torrance M, Adame A et al(2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci 27, 1981-1991   DOI
15 Muresan Z and Muresan V (2005) c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein. J Neurosci 25, 3741-3751   DOI
16 Dickens M, Rogers JS, Cavanagh J et al (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696   DOI
17 Bennett BL, Sasaki DT, Murray BW et al (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98, 13681-13686   DOI
18 Yoon SY, Choi JE, Yoon JH, Huh JW and Kim DH (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis 22, 435-444   DOI
19 Yoon S, Choi J, Yoon J, Huh JW and Kim D (2006) Okadaic acid induces JNK activation, bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons. Neurosci Lett 394, 190-195   DOI
20 Inomata H, Nakamura Y, Hayakawa A et al (2003) A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J Biol Chem 278, 22946-22955   DOI
21 Jiang S, Li Y, Zhang X, Bu G, Xu H and Zhang YW (2014) Trafficking regulation of proteins in Alzheimer's disease. Mol Neurodegener 9, 6   DOI
22 Kang J, Lemaire HG, Unterbeck A et al (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736   DOI
23 Suzuki T and Nakaya T (2008) Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 283, 29633-29637   DOI
24 Pastorino L, Sun A, Lu PJ et al (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534   DOI
25 Feyt C, Pierrot N, Tasiaux B et al (2007) Phosphorylation of APP695 at Thr668 decreases gamma-cleavage and extracellular Abeta. Biochem Biophys Res Commun 357, 1004-1010   DOI
26 Whitmarsh AJ (2006) The JIP family of MAPK scaffold proteins. Biochem Soc Trans 34, 828-832   DOI
27 Park JS, Kim DH and Yoon SY (2016) Regulation of amyloid precursor protein processing by its KFERQ motif. BMB Rep [Epub ahead of print]
28 Abe N, Almenar-Queralt A, Lillo C et al (2009) Sunday driver interacts with two distinct classes of axonal organelles. J Biol Chem 284, 34628-34639   DOI
29 Cho K, Cho MH, Seo JH et al (2015) Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease. Aging Cell 14, 878-886   DOI
30 Song HL, Shim S, Kim DH et al (2014) beta-Amyloid is transmitted via neuronal connections along axonal membranes. Ann Neurol 75, 88-97   DOI
31 Lee JH, Kim IW, Kim SH et al (2015) Anticancer activity of CopA3 dimer peptide in human gastric cancer cells. BMB Rep 48, 324-329   DOI